Lead Product(s) : Anacaulase-bcdb
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
MediWound Reports Positive Results from U.S. NexoBrid® Expanded Access Protocol
Details : NexoBrid (anacaulase-bcdb) is a topically administered biological product that enzymatically removes nonviable burn tissue, approved the treatment of severe burns.
Brand Name : NexoBrid
Molecule Type : Large molecule
Upfront Cash : Not Applicable
August 05, 2024
Lead Product(s) : Anacaulase-bcdb
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?